Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune-evasion. Surface is based in Cambridge, Mass.
Company Growth (employees)
Cambridge, US
Size (employees)
43 (est)+11%
Surface Oncology was founded in 2014 and is headquartered in Cambridge, US

Surface Oncology Office Locations

Surface Oncology has an office in Cambridge
Cambridge, US (HQ)
215 First Street, Suite 400-S

Surface Oncology Data and Metrics

Summary Metrics

Founding Date


Total Funding

$35 m

Latest funding size

$35 m

Time since last funding

over 2 years


Surface Oncology's latest funding round in January 2015 was reported to be $35 m. In total, Surface Oncology has raised $35 m

Traffic Overview of Surface Oncology

Surface Oncology News and Updates

Big Tech And Pharma Bet On Cancer Therapy Startups: Celgene, Novartis, Pfizer, and Google’s Investments

Corporate interest in life-science startups developing cancer therapies has been increasing over the years. Corporate-backed deals are up from around 30 in 2012 to nearly 50 so far this year (as of 10/26/16). Apart from big pharma companies like Novartis, … Continued

Surface Oncology Company Life and Culture

You may also be interested in